Demand for weight-loss drugs, including GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, has surged in the United States. In May 2024, a KFF Health Tracking Poll found that approximately 6 ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

James van Geelen, founder of Citrini Research, is focused on the next stage of AI, surrounding humanoid robots.

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...

It said it will also be adding two new doses, as competition in the ... ruling that there’s no longer a shortage of weight-loss drugs that had allowed for alternatives to be made, sending ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...